About Algenex

Algenex is a developer of vector-based innovative technologies designed to manufacture recombinant proteins. The company's technologies use a baculovirus expression vector system for vaccine manufacturing, diagnostic reagents, crystallography, HTS and therapeutic molecules, enabling users to enjoy unprecedented performance and proteolysis reduction.

Company Highlights
Year Founded

1960

icon-altEmployees

2

Location (HQ)

DEU

Since Last Funding

5 years 6 months

Monthly Website Visitors

357

icon-altTotal Investment Amt

$4.5M

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Manufacturing

Biotechnology

Pharmaceutical

Facilities Services